Application Notes & Case Studies
-
Fortrea Optimizes Site Matching On Retina Clinical Trials
6/27/2025
Faced with challenges in engaging clinical trial sites within the retina research landscape, Fortrea sought a partnership that leverages RWD to streamline site feasibility assessments.
-
Pioneering Cancer Research Meets Unparalleled Veeva Vault Integration
6/26/2025
A biotech company revolutionizing cancer treatment faced delays due to a complex, error-prone document review process. Discover how integrating an innovative strategy transformed their workflow.
-
Rapid Results In A High-Stakes Dry Eye Disease Trial
6/26/2025
This time-sensitive Phase III trial in dry eye disease required precision project management leveraging strong site relationships, ophthalmology-specific expertise, and data-driven site selection.
-
Global Start-Up For Multinational Geographic Atrophy Trial
6/26/2025
This partnership allowed a leading biopharmaceutical company to navigate the complexities of a Phase IIb study investigating a novel pegylated RNA adapter for geographic atrophy secondary to dry AMD.
-
Data Key In Addressing Patient Recruitment Challenges
6/19/2025
Explore how a Phase II trial for extensive-stage and previously treated small cell lung cancer overcame recruitment challenges with a data-driven solution designed to surface protocol-matched patients.
-
Precision Project Management In Action
6/12/2025
Discover how a tailored, risk-based project management approach was used to overcome the challenges of a complex Phase I/IIa FIH multi-country study of an advanced therapy medicinal product (ATMP).
-
Optimizing EDC Strategy And Data Collection for a Rare Disease Trial
6/11/2025
Explore how Veristat created a forward-looking roadmap for EDC and CRFs integration for a small biotech sponsor, ensuring a future-ready data ecosystem without overcomplicating current operations.
-
When Science And Humanity Become Inseparable
6/11/2025
Learn how kindness transformed the clinical trial experience for pediatric rare disease participants in a global study.
-
Running A 697-Patient MS Study Through Crisis And Complexity
6/10/2025
Review an ongoing Phase III open-label extension study evaluating the long-term safety and efficacy of ublituximab in patients with relapsing multiple sclerosis.
-
Boosting Recruitment Strategy For Phase III Study In Ulcerative Colitis
6/10/2025
Learn about the successful execution of a challenging three-arm, randomized, placebo-controlled Phase 3 study in Ulcerative Colitis despite strict inclusion criteria and a limited patient pool.